Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.48 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.48 |
| ▸ | ABAT | P80404 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.42 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.39 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24628725 | 0.93 | DRD1 (0.44) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL12669932 | 0.87 | PARP10 (0.52) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| Benzaldehyde SCHEMBL29291275 | 0.82 | ALDH1A1 (0.67) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL3074403 | 0.80 | CYP2A6 (0.50) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL5469857 | 0.80 | CYP2A6 (0.50) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL14327704 | 0.79 | CA2 (0.55) | CYP2A6HSD17B10ALDH1A1KDM4ETP53 | |
| SCHEMBL31171 | 0.78 | CYP2A6 (0.69) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL4956384 | 0.78 | CYP2A6 (0.69) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL234461 | 0.78 | ALDH1A1 (0.58) | HSD17B10ALDH1A1TSHRKDM4ETP53 | |
| SCHEMBL12632557 | 0.76 | CYP2A6 (0.46) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108727147-A | A kind of aldehyde Knoevenagel condensation reaction methods under the conditions of no catalyst or solvent | 南京林业大学 | 2018-11-02 | — | — | CN | claimed |
| CN-108530410-A | A method of dihydropyran ring is built by benzaldehyde, α-methylstyrene class compound and dimethyl sulfoxide jointly | 沅江华龙催化科技有限公司 | 2018-09-14 | — | — | CN | claimed |
| US-20230250364-A1 | LAUNDRY CARE COMPOSITIONS, METHODS, AND TEST KITS FOR DETERMINING AUTHENTICITY | PROCTER & GAMBLE (US) | 2023-08-10 | — | — | US | disclosed |
| US-11542267-B2 | Cryptate compounds | AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) | 2023-01-03 | — | — | US | disclosed |
| EP-3838957-A1 | POLYIMINES AND USES THEREOF | BOSTIK SA (FR) | 2021-06-23 | — | — | EP | disclosed |
| EP-3763225-A1 | BLACK RICE EXTRACT FERMENTS AND THE PREPARATION METHODS AND APPLICATIONS THEREOF | TCI Co., Ltd. (TW) | 2021-01-13 | — | — | EP | disclosed |
| CN-108727147-A | A kind of aldehyde Knoevenagel condensation reaction methods under the conditions of no catalyst or solvent | 南京林业大学 | 2018-11-02 | — | — | CN | disclosed |
| CN-104465106-B | For the electricity-polymer coated of wet electrolytic capacitor | AVX公司 | 2018-06-26 | — | — | CN | disclosed |
| CN-104271557-B | The suppressing method of deubiquitination activity | 威沃路克斯股份公司 | 2017-12-05 | — | — | CN | disclosed |
| EP-2571503-B1 | COMPOSITIONS AND THEIR USE IN TREATING NEOPLASIA, INFLAMMATORY DISEASE AND OTHER DISORDERS | DANA FARBER CANCER INST INC (US) | 2015-01-07 | — | — | EP | disclosed |
| WO-2014106554-A1 | (ETHYLENE, VINYL ACETAL) COPOLYMERS AND THEIR USE IN LITHOGRAPHIC PRINTING PLATE PRECURSORS | AGFA GRAPHICS NV (BE) | 2014-07-10 | — | — | WO | disclosed |
| US-7812051-B2 | Pharmaceutical compositions of β-lapachone and β-lapachone analogs with improved tumor targeting potential | ARQULE, INC. (US) | 2010-10-12 | — | — | US | disclosed |
| US-20100256155-A1 | METHOD FOR INHIBITING GROWTH OF CANCER CELLS AND CELL TELOMERE AND DISEASES OF CELL PROLIFERATION BY USING HETEROANNELATED ANTHRAQUINONE DERIVATIVE COMPOUNDS | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2010-10-07 | — | — | US | disclosed |
| US-20100184986-A1 | SULFONAMIDE-BASED ORGANOCATALYSTS AND METHOD FOR THEIR USE | The State of Oregon acting by and through the State Board of Higher Education on behalf of Orego | 2010-07-22 | — | — | US | disclosed |
| US-20090253707-A1 | HETEROANNELATED ANTHRAQUINONE DERIVATIVES AND THE SYNTHESIS METHOD THEREOF | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2009-10-08 | — | — | US | disclosed |
| US-20090227553-A1 | SYNTHESIS OF CHLORINS AND PHORBINES WITH ENHANCED RED SPECTRAL FEATURES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-09-10 | — | — | US | disclosed |
| US-20090048343-A1 | Compounds and Their Salts Specific to the PPAR Receptors and the EGF Receptors and Their Use in the Medical Field | NOGRA PHARMA LIMITED (IE) | 2009-02-19 | — | — | US | disclosed |
| US-20080311516-A1 | INKLESS PRINTING PAPER AND METHOD | XEROX CORPORATION (US) | 2008-12-18 | — | — | US | disclosed |
| US-7329681-B2 | Inhibitors of IMPDH enzyme | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-02-12 | — | — | US | disclosed |
| CN-101010312-A | Quaternary salt chemoattractant cytokine receptor 2 antagonists | JANSSEN PHARMACEUTICA NV (BE) | 2007-08-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227553-A1 | SYNTHESIS OF CHLORINS AND PHORBINES WITH ENHANCED RED SPECTRAL FEATURES | CRY1, CRY2, HCCS | CYP2A6 1711/4885HSD17B10 3174/4885ALDH5A1 1531/4885 |
| US-20090048343-A1 | Compounds and Their Salts Specific to the PPAR Receptors and the EGF Receptors and Their Use in the Medical Field | EGFR, ERBB3, FGFR3 | CYP2A6 547/4885HSD17B10 1558/4885ALDH5A1 3431/4885 |
| US-11542267-B2 | Cryptate compounds | HCCS, SQOR, NQO1 | CYP2A6 175/4885HSD17B10 430/4885ALDH5A1 79/4885 |
| US-20100184986-A1 | SULFONAMIDE-BASED ORGANOCATALYSTS AND METHOD FOR THEIR USE | ALDH7A1, SULT1A1, SULT2A1 | CYP2A6 370/4885HSD17B10 830/4885ALDH5A1 29/4885 |
| US-20090253707-A1 | HETEROANNELATED ANTHRAQUINONE DERIVATIVES AND THE SYNTHESIS METHOD THEREOF | ANTXR2, RCC2, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | CYP2A6 104/4885HSD17B10 176/4885ALDH5A1 1125/4885 |
| US-20100256155-A1 | METHOD FOR INHIBITING GROWTH OF CANCER CELLS AND CELL TELOMERE AND DISEASES OF CELL PROLIFERATION BY USING HETEROANNELATED ANTHRAQUINONE DERIVATIVE COMPOUNDS | TELO2, TERT, POT1 | CYP2A6 2263/4885HSD17B10 468/4885ALDH5A1 2016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.